Objective: To determine the obstetric outcome in terms of duration of labour and mode of delivery between the walking epidural analgesia with 0.1% Bupivacaine + 0.5% tramadol and routine labour practice.
Study Design: Non-randomized controlled trial.
Place And Duration Of Study: Department of Anaesthesia, Military Hospital, Rawalpindi, from August 2004 to July 2007.
Methodology: Consecutive 50 primiparous patients, ASA-I, coming to antenatal clinic for routine delivery were included in control group-A, and consecutive 50 primiparous ASA-I, coming to antenatal clinic and requesting for painless delivery were included in group-B. In group-A, only injection Nalbuphine 10 mg intramuscular was given when pain was unbearable, on patient's request as a routine practice. In group-B epidural analgesia was given with 15 ml of 0.1% Bupivacaine + 0.5 mg/ml Tramadol. First stage, second stage and total duration of labour were noted. Mode of delivery was also recorded in both groups. Patient satisfaction was assessed by interviewing the parturient at evening round after delivery.
Results: In group-A, first stage duration of labour was 6.72 + or - 1.16 hours and in group-B, it was 4.03 + or - 1.00 hours, (p < 0.001). Second stage of labour in group-A was 0.55 + or - 0.35 hours and in group-B it was 0.67 + or - 0.33 hours; (p=0.072). Total duration of labour, in group-A was 7.57 + or - 1.13 hours and in group-B it was 4.77 + or - 1.21 hours, (p < 0.001). In group-A 46/50 (92%) patients were delivered spontaneously, while 4/50 (8%) required instrumental assistance. In group-B 36/50 (72%) patients were delivered spontaneously and instrumental deliveries were 13/50 (26%) (p=0.015). One patient developed fetal distress and went through cesarean section in group B. Patient satisfaction was excellent in 88% of group-B parturients.
Conclusion: Epidural analgesia with combination of low concentration of Bupivacaine, injection Tramadol and ambulation markedly reduce the duration of labour.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Artificial intelligence-based cardiovascular/stroke risk stratification in women affected by autoimmune disorders: a narrative survey.
Rheumatol Int
January 2025
Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA, 95661, USA.
Women are disproportionately affected by chronic autoimmune diseases (AD) like systemic lupus erythematosus (SLE), scleroderma, rheumatoid arthritis (RA), and Sjögren's syndrome. Traditional evaluations often underestimate the associated cardiovascular disease (CVD) and stroke risk in women having AD. Vitamin D deficiency increases susceptibility to these conditions.
View Article and Find Full Text PDFTOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer.
Clin Cancer Res
January 2025
University of California, Los Angeles, Los Angeles, CA, United States.
Purpose: Antibody-drug conjugates (ADCs) harboring topoisomerase I (TOP1) inhibitor payloads have improved survival for patients with metastatic breast cancer (MBC). However, knowledge of ADC resistance mechanisms and potential impact on sequential use of ADCs is limited. Here, we report the incidence and characterization of TOP1 mutations arising in the setting of ADC resistance in MBC.
View Article and Find Full Text PDFThe Impact of Increased Heat on the Physical, Mental, and Social Health Domains of Adults in the United Arab Emirates in 2024.
Cureus
December 2024
Department of Community Medicine, College of Medicine, Gulf Medical University, Ajman, ARE.
Objectives: The purpose of this research was to assess the impact of exposure to heat on the physical, social, and mental health domains of adults residing in the United Arab Emirates (UAE), where the region faces great increases in temperature due to climate change. Previous research has focused mainly on physical health outcomes; this research addressed the expansive impacts of mental and social health, which remain understudied in the region.
Methods: A cross-sectional study surveyed 397 adults in the UAE using a structured questionnaire.
Systemic Medications and Their Ocular Side Effects.
Cureus
December 2024
Department of Clinical Research, Clinical Virtual Research Center, Wayne, USA.
Most of the drugs that we use in our everyday clinic cause ocular side effects or toxicity, depending on the drug duration and dose. Eye care physicians should be familiar with any possible ocular side effects linked to these medications, which could save the physicians' time to determine the diagnosis of the ocular irritation or toxicity. Not all medications are listed in this review, but we did go over the most common systemic medications based on our experience seeing patients in our everyday clinic.
View Article and Find Full Text PDFPain Management in Fibromyalgia: Evaluating the Roles of Pregabalin, Duloxetine, and Milnacipran.
Cureus
December 2024
Family Medicine, Holy Family Hospital, Rawalpindi, PAK.
Introduction Fibromyalgia is a chronic pain disorder characterized by widespread pain, fatigue, and sleep disturbances. The purpose of this study was to compare how well duloxetine, pregabalin, and milnacipran worked for fibromyalgia patients in terms of pain management, quality of life, and sleep quality. Methodology A prospective cohort research study with 193 fibromyalgia patients was carried out at the Abbas Institute of Medical Sciences, Muzaffarabad, Pakistan.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!